Angelo Zanniti/LinkedIn
Jun 15, 2026, 13:05
Angelo Zanniti: Back from EHA 2026 Congress
Angelo Zanniti, Medical Biotechnologist at CEINGE Official Profile, shared a post on LinkedIn:
“Back from an inspiring few days at the EHA 2026 Congress in Stockholm.
It was a great opportunity to connect with colleagues, share experiences, and discover the latest advances in hematology and molecular diagnostics.
Conferences like these remind us how quickly our field is evolving and how important collaboration is in driving innovation and improving patient care.
Grateful for the experience and looking forward to putting new ideas into practice.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 13:51Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
-
Jun 15, 2026, 13:37Katja Sockel: EHA 2026 Inspires New Ideas and Global Connections
-
Jun 15, 2026, 13:25Srishti Goyal։ India’s Blood Donation Journey – Looking Beyond the Numbers
-
Jun 15, 2026, 13:22Debra BenAvram: Every Two Seconds – Someone Needs Blood
-
Jun 15, 2026, 13:13Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
-
Jun 15, 2026, 12:46Moonmoon Kazi: Climb Bio Presents Phase 1b ITP Trial Data at EHA 2026
-
Jun 15, 2026, 12:44Wolfgang Miesbach: Base Editing and the Future of Sickle Cell Disease Therapy